Redica Systems
  • Login
  • Request a Demo
  • Products
    • Regulatory Intelligence
    • Inspection Intelligence
    • Site Intelligence
  • Solutions
    • Redica Systems Pharma Intelligence
    • Redica Systems MedTech Intelligence
  • Data & Services
    • Redica App
    • Catalyst
  • Company
    • About Us
    • People
    • Careers
    • Press
  • Resources
    • Blog
    • Assessments
    • Reports
    • Webinars
    • Glossary
Redica Systems
    • Regulatory Intelligence
    • Inspection Intelligence
    • Site Intelligence
    • Redica Systems Pharma Intelligence
    • Redica Systems MedTech Intelligence
    • Redica App
    • Catalyst
    • About Us
    • People
    • Careers
    • Press
    • Blog
    • Assessments
    • Reports
    • Webinars
    • Glossary
  • Login
  • Request a Demo

Resources

Law Street | April 10, 2024

This article covers J&J’s acquisition of Shockwave Medical and other cardiac products acquired previously from Impella, which an FDA recall notice linked to at least 49 deaths and 129 serious injuries. Redica Systems provided data and insights for this article. Read the full story here.

Science | March 11, 2024

This article covers the Inspection findings for possible Alzheimer’s drugs by Hoau-Yan Wang, an academic partner of Cassava Sciences. Science contacted Redica Systems to review the findings and get insights from our CEO, Michael de la Torre, and Senior Quality Expert, Jerry Chapman. Read the full article here.

Reuters | March 1, 2024

This article covers problems with Musk’s Neuralink brain implant. Redica Systems provided data and inspection reports for the article. Read the full coverage here.

Webinar – Cultivating Successful Outsourcing Partnerships: The Power of Cultural Fit

Webinar – Vendor Management through Conforming Contracts

Webinar – Quality Intelligence Q&A with Peter Baker and Ulrich Köllisch

Report – First FDA Warning Letter to Excipient Manufacturer Provides Lessons

Report – Intas Pharmaceuticals’ Troubles with FDA Continue

Applied Clinical Trials | August 16, 2023

This atricle covers Pfizer ending their relationship with decentralized clinical trial (DCT) specialist CareAccess and how companies work together on GCP adherence. Our Senior GMP Quality Expert, Jerry Chapman gave his insights on the matter. Read the full article here.

Report – Expert Analysis: 22 years of FDA Drug GMP 483s

« Older Entries
Newer Entries »
Company
  • About Redica Systems
  • People
  • Careers
  • Press
  • Contact Us
Catalyst
  • Redica Catalyst
  • Redica ID
  • Enrichment
  • Knowledge Graph
  • Redica Ontologies
Use Cases
  • For Pharma
  • For MedTech
  • Inspection Preparation
  • Vendor Quality
  • Regulatory Surveillance
Resources
  • Assessments
  • Reports
  • Webinars
  • Document Store
  • Blog
  • Glossary

© 2026 Redica. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Status